Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1

Journal of Experimental Medicine

Volumn 184, Issue 3, 1996, Pages 1111-1126

  Lorenz, Ulrike ^a,b,c   Bergemann, Andrew D ^b   Steinberg, Howard N ^a   Flanagan, John G ^a   Liji, Xiantang ^a   Gallig, Stephen J ^a   Neel, Benjamin G ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE LOCUS; GENETIC ANALYSIS; GENOTYPE; HEMATOPOIETIC CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; STEM CELL;

EID: 0029787630     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.3.1111     Document Type: Article

References (50)

1. Yi, T., andJ.N. Ihle. 1993. Association of hematopoietic cell phosphatase with c-kit after stimulation with c-kit ligand. Mol. Cell. Biol. 13:3350-3358.
2. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell. 61: 203-212.
3. Yarden, Y., and A. Ullrich. 1988. Growth factor receptor tyrosine kinases. Annn. Rev. Biocliem. 57:443-178.
4. Ihle, J.N. 1995. Cytokine receptor signalling. Nature (Loud.). 377:591-594.
5. Miyajima, A., A.L. Mui, T. Ogorochi, and K. Sakamaki. 1993. Receptors for granulocyte-niacrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood. 82: 1960-1974.
6. Koch, C., D. Anderson, M. Moran, C. Ellis, and T. Pawson. 1991. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science (Wash. DC). 252: 668-674.
7. Margolis, B. 1992. Proteins with SH2 domains: transducers in the tyrosine kinase signaling pathway. Cell Growth Differ. 3: 73-80.
8. Pawson, T., and G. Gish. 1992. SH2 and SH3 domains: from structure to function. Cell. 71:359-362.
9. Clark, S.G., MJ. Stem, and H.R. Horvitz. 1992. C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature (Lend.). 356:340-344.
10. Raabe, T., J.P. Olivier, 13. Dickson, X. Liu, G.D. Gish, T. Pawson, and E. Hafen. 1995. Biochemical and genetic analysis of the Drk SH2/SH3 adaptor protein of Drosophik. EMBO (Enr. Mol. Biol. Organ.)}. 14: 2509-2518.
11. Simon, M.A., G.S. Dodson and G.M. Rubin. 1993. An SH3-SH2-SH3 protein is required for p21s activation and binds to Sevenless and Sos proteins in vitro. Cell. 73:169-177.
12. Doyle, HJ., and J.M. Bishop. 1993. Torso, a receptor tyrosine kinase required for embryonic pattern formation, shares substrates with the sevenless and EGF-R pathways in Drosophila. Genes & Dcv. 7:633-646.
13. Little, C.C., and A.M. Cloudman. 1937. The occurrence of a dominant spotting mutation in the house mouse. Proc. Nail. Acad. Sei. USA. 23:535-537.
14. Nocka, K.J. Buck, E. Levi, and P. Besmer. 1990. Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO (Eur. Mol. Biol. Organ.) J. 9:32873294.
15. Nocka, K.J.C. Tan, E. Chiu, T.Y. Chu, P. Ray, P. Traktman, and P. Besmer. 1990. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/ white spotting locus: W37, Wv, W41 and W. EMBO (Enr. Mol. Biol. Onan.)J. 9:1805-1813.
16. Qiu, F.H., P' Ray, K. Brown, P.E. Barker, S.Jhanwar, F.H. Ruddle, and P. Besmer. 1988. Primary structure of c-kit: relationship with the CSF1/PDGF receptor kinase familyoncogenic activation of v-kit involves deletion of extracellular domain and C-tenninus. EMBO (Enr. Mol. Biol. Organ.) J. 7:1003-1011.
17. Yarden, Y., WJ. Kuang, F.T. Yang, L. Coussens, S. Muuemitsu, TJ. Dull, E. Chen, J. Schlessinger, U. Franke, and A. Ullrich. 1987. Human proto-oncogene c-Kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EA/BO (Enr. Mol. Biol. Organ.)]. 6:3341-3351.
18. Besmer, P., J.E. Murphy, P.C. George, F.H. Qiu, PJ. Bergold, and L. Ledennan. 1986. A new transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature (Land.). 320:415-421.
19. Galli, S.J., K.M. Zsebo, and E.N. Geissler. 1995. The kit Ligand, Stem Cell Factor. Adv. Immimol. 55:1-96.
20. Adachi, M., E.H. Fischer, J. Ihle, K. Imai, F. Jirik, B. Neel, T. Pawson, S.-H. Shen, M. Thomas, A. Ullrich, and Z. Zhao. 1996. Mammalian SH2-containing protein tyrosine phosphatases. Cell. 85:15.
21. Plutzky, J., E.G. Neel, and R.D. Rosenberg. 1992. Isolation of a novel src homology 2 (SH2) containing tyrosine phosphatase. Proc. Natl. Acad. Sei. USA. 89:1123-1127.
22. Shen, S.-H., L. Bastien, B.I. Posner, and P. Chrétien. 1991. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature (Land.). 352:736-739.
23. Yi, T., J.L. Cleveland, andJ.N. Ihle. 1992. Protein tyrosine phosphatase containing SH2 domains: Characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12pl2-13. Mol. Cell. Biol. 12:836-846.
24. Matthews, R.J., D.B. Bowne, E. Flores, and M.L. Thomas. 1992. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine rich sequences. Mol. Cell. Biol. 12:2396-2405.
25. Klingmueller, U., U. Lorenz, L.C. Cantley, B.C. Neel, and H.F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:729-738.
26. David, M., H.E. Chen, S. Goelz, A.C. Larner, and B.C. Neel. 1995. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-con-taining tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 15: 7050-7058.
27. Plas, D.R., R. Johnson, J.T. Pingel, R.J. Matthews, M. Dalton, G. Roy, A. Chan, and M.L. Thomas. 1996. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science (Wash. DC). 272:1173-1176.
28. Lorenz, U., K.S. Ravichandran, S.J. BurakofT, and B.C. Neel. 1996. Lack of SHPTP1 results in src-family kinase hyper-activation and thymocyte hyper-responsiveness. Proc. Natl. Acad. Sei. USA. In press.
29. Chen, H.E., S. Chang, T. Trub, and B.C. Neel. 1996. Regulation of Colony-Stimulating Factor 1 Receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. A/oJ. Cell Biol. 16:3685-3697.
30. Reith, A.D., R. Rottapel, E. Giddens, C. Brady, L. Forrester, and A. Bernstein. 1990. W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. Genes & Dcv. 4: 390-400.
31. Shultz, L.D., P.A. Schweitzer, T.V. Rajan, T. Yi, J.N. Ihle, R.J. Matthews, M.L. Thomas, and D.R. Beier. 1993. Mutations at the nuirine motheaten locus are within the hematopoietic cell protein phosphatase (HCPH) gene. Cell. 73: 1445-1454.
32. Tsui, H.W., K.A. Siminovitch, L. deSouza, and F.W.L. Tsui. 1993. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genetics. 4:124-129.
33. Shultz, L.D., and C.L. Sidman. 1987. Genetically determined murine models of immunodeficiency. Annu. Rev. Iniiininol. 5: 367-403.
34. Reith, A.D., C. Ellis, S.D. Lyman, D.M. Anderson, D.E. Williams, A. Bernstein, and T. Pawson. 1991. Signal transduction by normal isoforms and \V mutant variants of the Kit receptor tyrosine kinase. EMBO (Em. Mol. Biol. Organ.) J. 10:2451-2459.
35. Tsai, M., T. Takeishi, H. Thompson, K.E. Langley, K.M. Zsebo, D.D. Metcalfe, E.N. Geissler, and SJ. Galli. 1991. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sei. USA. 89:6382-6386.
36. Dvorak, H.F., J.M.C. Mihm, A. M. Dvorak, A. M. Barnes, E. J. Manseau, and S. J. Galli. 1979. Rejection of first-set skin allografts in man. The microvasculature is the critical target of the immune response. J. Exp. Mcd. 150:322-337.
37. Galli, S. J. and I. Hammel. 1984. Unequivocal delayed hyper-sensitivity in mast cell-deficient and beige mice. Science (Wash. DC). 226:710-713.
38. Yano, H., B. K. Wershil, N. Arizono, and S. J. Galli. 1989. Substance P-induced augmentation of cutaneous vascular permeability and granulocyte in filtration in mice is mast cell dependent. J. Clin. Invest. 84: 1276-1286.
39. Wershil, B. K., T. Murakami, and S.J. Galli. 1988. Mast cell dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate.J. Iimmiiiol. 140:2356-2360.
40. Lorenz, U., K.S. Ravichandran, D. Pei, C.T. Walsh, S.J. Burakoff, and B.C. Neel. 1994. Lck-dependent tyrosyl phosphorylation of the phosphotyrosine phosphatase SH-PTP1 in murine T cells. Mol. Cell. Biol. 14:1824-1834.
41. Vambutas, V., D.R. Kaplan, M.A. Sells, and J. Chernoff. 1995. Nerve growth factor stimulates tyrosine phosphorylation and activation of src-homology-containing proteintyrosine phosphatase 1 in PC12 cells. J. Biol. Clicm. 270: 25629-25633.
42. van Zant, G., and L. Shultz. 1989. Hématologie abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). E\p. Hematol. 17:81-87.
43. Broxmeyer, H.A., and D.E. Williams. 1988. The production of myeloid blood cells and their regulation during health and disease. Crit. Rev. Oneol-Hcinatol. 8:173-226.
44. De Jong, M.O., G. Wagemaker, and A.W. Wognum. 1995. Separation of myeloid and erythroid progenitors based on expression of CD34 and c-Kit. Blood. 86:4076-4085.
45. Yi, T., A.L.-F. Mui, G. Krystal, and J.N. Ihle. 1993. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol. Cell. Biol. 13: 7577-7586.
46. Tsai, M., S.-Y. Tarn, and S.J. Galli. 1993. Distinct patterns of early response gene expression and proliferation in mouse mast cells stimulated by stem cell factor, interleukin-3, or IgE and antigen. Enr.J. Imiminol. 23: 867-872.
47. Broxmeyer, H.E., S. Cooper, L. Lu, G. Hagve, D. Anderson, D. Cosman, S.D. Lyman, and D.E. Williams. 1991. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Bhod. 77:2142-2149.
48. Avanzi, G.G., P. Lista, B. Giovinazzo, R. Miniero, G. Saglio, G. Benetton, R. Coda, G. Cattoretti, and L. Pegoraro. 1988. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br.J. Hematol. 69:359-366.
49. Galli, S.J., A.M. Dvorak, J.A. Marcum, T. Ishizaka, G. Nabel, H. Der Simonoian, K. Pyne, J.M. Goldin, R.D. Rosenberg, H. Cantor, and H.F. Dvorak. 1982. Mast cell clones: a model for the analysis of cellular maturation. J. Cell Biol. 95: 435-444.
50. Nabel, G., S.J. Galli, A.M. Dvorak, H.F. Dvorak, and H. Cantor. 1981. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature (Land.). 291:332-334.